| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmaceutical Sciences, School of Pharmacy, Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, Colorado 80262 [A. M. M., K. M. K.], and Medical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom [W. A. E., M. F. W. F.]
Chronic butylated hydroxytoluene (BHT) treatment after a single administration of a carcinogen increases lung tumor multiplicity in some inbred strains of mice. We report that BALB/cOla and BALB/cByJ mice given a low dose (10 µg/g of body weight) of 3-methylcholanthrene (MCA) develop no lung tumors unless this is followed by chronic BHT exposure. Slightly higher MCA doses (15 and 25 µg/g) induce low lung tumor multiplicities (0.6 and 1.9 tumors/mouse, respectively) that are increased 1226-fold by chronic BHT administration. This low-dose MCA/BHT model in BALB mice will facilitate the identification of genes regulating susceptibility to lung tumor promotion and pulmonary chemopreventative agents that act at a postinitiation site.
1 Supported by USPHS Grant CA33497 and by Grant 9510 from the American Institute for Cancer Research.
2 To whom requests for reprints should be addressed, at Department of Pharmaceutical Sciences, School of Pharmacy. Colorado Cancer Center, University of Colorado Health Sciences Center, 4200 East 9th Street, Denver, CO 80262. Phone: (303) 315-4579; Fax: (303) 315-6281; E-mail: al.malkinson@uchsc.edu.
Received 4/ 7/97. Accepted 6/ 2/97.
This article has been cited by other articles:
![]() |
A. K. Bauer, D. Dixon, L. M. DeGraff, H.-Y. Cho, C. R. Walker, A. M. Malkinson, and S. R. Kleeberger Toll-Like Receptor 4 in Butylated Hydroxytoluene-Induced Mouse Pulmonary Inflammation and Tumorigenesis J Natl Cancer Inst, December 7, 2005; 97(23): 1778 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Blaine, A. M. Meyer, G. Hurteau, M. Wick, J. A. Hankin, R. C. Murphy, A. J. Dannenberg, M. W. Geraci, K. Subbaramaiah, and R. A. Nemenoff Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice Carcinogenesis, January 1, 2005; 26(1): 209 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF] |
||||
![]() |
L. R. Kisley, B. S. Barrett, L. D. Dwyer-Nield, A. K. Bauer, D. C. Thompson, and A. M. Malkinson Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice Carcinogenesis, October 1, 2002; 23(10): 1653 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
Final Report on the Safety Assessment of BHT International Journal of Toxicology, October 1, 2002; 21(2_suppl): 19 - 94. [Abstract] [PDF] |
||||
![]() |
A. M. Malkinson, R. A. Radcliffe, and A. K. Bauer Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice Carcinogenesis, March 1, 2002; 23(3): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Keith, Y. E. Miller, Y. Hoshikawa, M. D. Moore, T. L. Gesell, B. Gao, A. M. Malkinson, H. A. Golpon, R. A. Nemenoff, and M. W. Geraci Manipulation of Pulmonary Prostacyclin Synthase Expression Prevents Murine Lung Cancer Cancer Res., February 1, 2002; 62(3): 734 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Gressani, S. Leone-Kabler, M.G. O'Sullivan, L.D. Case, A. M. Malkinson, and M. S. Miller Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene Carcinogenesis, November 1, 1999; 20(11): 2159 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Brown, A. M. Malkinson, D. E. Rannels, and S. R. Rannels Compensatory Lung Growth after Partial Pneumonectomy Enhances Lung Tumorigenesis Induced by 3-Methylcholanthrene Cancer Res., October 1, 1999; 59(20): 5089 - 5092. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |